Crescent Biopharma to Present at the TD Cowen 45th Annual Health Care Conference
Portfolio Pulse from
Crescent Biopharma is set to present at the TD Cowen 45th Annual Health Care Conference, focusing on their lead program CR-001, a bispecific antibody for solid tumors.
February 26, 2025 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
TD Cowen is hosting its 45th Annual Health Care Conference where Crescent Biopharma will present its lead program CR-001.
TD Cowen is the host of the conference where Crescent Biopharma will present. While this highlights TD Cowen's role in the healthcare sector, it does not directly impact its stock price.
CONFIDENCE 80
IMPORTANCE 30
RELEVANCE 50